DM Monitoring
LONDON: World shares hit a record high on Monday and oil surpassed $60 a barrel for the first time in a year, on hopes that a $1.9 trillion COVID-19 aid package will be passed by U.S. lawmakers as soon as this month.
Even news that South Africa had halted the rollout of AstraZeneca’s vaccine after a study showed it gave only limited protection against the country’s more contagious variant of the virus wasn’t going to put equity markets off.
MSCI’s 50-country index of world stocks hit its ninth record high of 2021 overnight as Tokyo’s Nikkei jumped on talk of Japan relaxing emergency restrictions and as China’s markets got busy before the start of the lunar new year.
Europe then made a strong start as higher oil prices and inflation expectations lifted basic resource and banking shares, and France’s Veolia launched a hostile 11.3 billion-euro takeover bid for waste and water rival Suez.
“A generalised risk-on tone is pushing stocks higher,” UniCredit’s analysts said in a note.
Bond markets were focused on how far inflation might rise if the current mix of stimulus, rising oil and food prices and expectations for a reopening economies continue to hold.
Ten-year U.S. Treasury yields, which are one of the main drivers of global borrowing costs, climbed to 1.2%, their highest since the peak of coronavirus uncertainty last March. Break-even rates, which are designed to account for inflation, traded as high as 2.21%, their highest since 2014.
In Europe, Germany’s 10-year yields were up 3 basis points at -0.415%, near five-month highs.
“It will be hard not to see inflation in something when we get what is likely to be a short-term stimulus boost,” Deutsche Bank’s Jim Reid said, referring to planned U.S. stimulus.
“Whether that will be in goods, wages or asset prices or all three remains to be seen, but it seems inevitable there will be an impact.”
Brent crude touched an intraday high of $60.06 a barrel, the highest since January last year.
Saudi Arabia’s pledge of extra supply cuts in February and March on the back of reductions by other OPEC members its allies, including Russia, is helping to balance global markets and support prices.
In a sign that supplies are tightening, the six-month Brent spread hit its highest in more than year, $2.45. OCBC’s economist Howie Lee said the Saudis had sent another “very bullish signal” last week by keeping its Asian prices unchanged.
“I don’t think anybody dares to short the market when Saudi is like this,” he said.
STIMULUS
Asia’s overnight rally had seen Japan’s Nikkei close up 2%, Chinese blue-chip shares advance 1.3% and Australian shares finish 0.6% higher.
Wall Street futures were also pointing higher after the Nasdaq and S&P 500 both climbed to record highs on Friday as weak monthly U.S. jobs data supported expectations of stimulus and after some strong corporate earning.
U.S. President Joe Biden and his Democratic allies in Congress forged ahead with their stimulus plan on Friday as lawmakers approved a budget outline that will allow them to muscle through in the coming weeks without Republican support.
U.S. Treasury Secretary Janet Yallen predicted the United States would reach full employment next year if Congress can pass its support package.
“That’s a big call, given full employment is 4.1%, but one that will sit well with the market at a time when the vaccination program is being rolled out efficiently in a number of countries,” said Chris Weston, Melbourne-based chief strategist at Pepperstone.
Expectations of a U.S. economic recovery have not boosted the dollar, though, “because this shift in prospects is seen by the market as part of a global recovery,” Westpac economists wrote in a note.
“Investors therefore favour risk taking, and so value the safety of the U.S. dollar less.”
Indeed, the dollar came off a four-month high against the Japanese yen to be last at 105.50.
The euro was weaker at $1.2027 after rising 0.7% on Friday to a one-week high.
The risk-sensitive Australian dollar eased from a one-week high to $0.7675 while South Africa’s rand fell nearly 0.5% after its vaccine troubles.
